The effect of structural modification of antimicrobial peptides on their antimicrobial activity, hemolytic activity, and plasma stability. 2021

Taoran Wang, and Cunbin Zou, and Na Wen, and Xingdong Liu, and Zhao Meng, and Siliang Feng, and Zhibing Zheng, and Qingbin Meng, and Chenhong Wang
State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, China.

In this article, a series of modifications were made on an antimicrobial peptide F2,5,12 W, including altering the amino acid sequence, introducing cysteine and other typical amino acids, developing peptide dimers via disulfide bonds, and conjugating with mPEG, in order to enhance the antimicrobial activity, plasma stability, and reduce the hemolytic activity of peptides. The results showed that mPEG conjugation could significantly improve the plasma stability and reduce the hemolytic activity of peptides, while the antimicrobial activity decreased meanwhile. However, altering the sequence of the peptide without changing its amino acid composition had little impact on its antimicrobial activity and plasma stability. The introduction of cysteine enhanced the plasma stability of peptides conspicuously, but at the same time, the increased hydrophobicity of peptides increased their hemolysis. The antimicrobial mechanism and cytotoxicity of the peptides with relatively high antimicrobial activity were also studied. In general, this study provided some ideas for the rational design and structure optimization of antimicrobial peptides.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D006461 Hemolysis The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity. Haemolysis,Extravascular Hemolysis,Intravascular Hemolysis,Extravascular Hemolyses,Haemolyses,Hemolyses, Extravascular,Hemolyses, Intravascular,Hemolysis, Extravascular,Hemolysis, Intravascular,Intravascular Hemolyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013211 Staphylococcus aureus Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.
D052899 Pore Forming Cytotoxic Proteins Proteins secreted from an organism which form membrane-spanning pores in target cells to destroy them. This is in contrast to PORINS and MEMBRANE TRANSPORT PROTEINS that function within the synthesizing organism and COMPLEMENT immune proteins. These pore forming cytotoxic proteins are a form of primitive cellular defense which are also found in human LYMPHOCYTES.

Related Publications

Taoran Wang, and Cunbin Zou, and Na Wen, and Xingdong Liu, and Zhao Meng, and Siliang Feng, and Zhibing Zheng, and Qingbin Meng, and Chenhong Wang
January 2017, Methods in molecular biology (Clifton, N.J.),
Taoran Wang, and Cunbin Zou, and Na Wen, and Xingdong Liu, and Zhao Meng, and Siliang Feng, and Zhibing Zheng, and Qingbin Meng, and Chenhong Wang
November 2012, Amino acids,
Taoran Wang, and Cunbin Zou, and Na Wen, and Xingdong Liu, and Zhao Meng, and Siliang Feng, and Zhibing Zheng, and Qingbin Meng, and Chenhong Wang
May 2017, Colloids and surfaces. B, Biointerfaces,
Taoran Wang, and Cunbin Zou, and Na Wen, and Xingdong Liu, and Zhao Meng, and Siliang Feng, and Zhibing Zheng, and Qingbin Meng, and Chenhong Wang
April 1993, Biochimica et biophysica acta,
Taoran Wang, and Cunbin Zou, and Na Wen, and Xingdong Liu, and Zhao Meng, and Siliang Feng, and Zhibing Zheng, and Qingbin Meng, and Chenhong Wang
August 2023, Antibiotics (Basel, Switzerland),
Taoran Wang, and Cunbin Zou, and Na Wen, and Xingdong Liu, and Zhao Meng, and Siliang Feng, and Zhibing Zheng, and Qingbin Meng, and Chenhong Wang
April 2024, International journal of molecular sciences,
Taoran Wang, and Cunbin Zou, and Na Wen, and Xingdong Liu, and Zhao Meng, and Siliang Feng, and Zhibing Zheng, and Qingbin Meng, and Chenhong Wang
March 2023, Biochemical and biophysical research communications,
Taoran Wang, and Cunbin Zou, and Na Wen, and Xingdong Liu, and Zhao Meng, and Siliang Feng, and Zhibing Zheng, and Qingbin Meng, and Chenhong Wang
January 1990, Biofizika,
Taoran Wang, and Cunbin Zou, and Na Wen, and Xingdong Liu, and Zhao Meng, and Siliang Feng, and Zhibing Zheng, and Qingbin Meng, and Chenhong Wang
August 2011, Molecular pharmaceutics,
Taoran Wang, and Cunbin Zou, and Na Wen, and Xingdong Liu, and Zhao Meng, and Siliang Feng, and Zhibing Zheng, and Qingbin Meng, and Chenhong Wang
August 2017, Peptides,
Copied contents to your clipboard!